Cigna beats profit estimates on lower-than-expected costs, pharmacy benefit boost
Aug 1 (Reuters) -Cigna CI.N reported a second-quarter profit on Thursday that beat Wall Street estimates, helped by lower-than-expected medical costs and strength in its pharmacy benefit management unit.
The industry has been contending with elevated medical costs since late last year, as older adults catch up on delayed procedures, and lower-than-expected payments from the government for managing healthcare for people aged 65 and older or with disabilities, under the Medicare plans.
Compared to UnitedHealth UNH.N and Humana HUM.N, Cigna has a much smaller presence in the Medicare Advantage (MA) market and is in the process of selling its MA business to Health Care Service Corp.
Cigna relies more on managing employer-sponsored healthcare plans.
While the company saw its medical care ratio - the percentage of premiums spent on medical care - rise to 82.3% from 81.2% a year earlier, it was lower than analysts expectations of 82.43%, according to LSEG estimates.
Cigna maintained its annual profit forecast of at least $28.40 per share, and said it continues to expect a medical care ratio between 81.7% and 82.5% for the year.
For 2024, analysts expect a profit of $28.51 per share and a medical care ratio of 82.08%.
Adjusted sales in Cigna's Evernorth unit, under which it operates pharmacy benefit management (PBM) business, jumped nearly 30% to $49.55 billion, for the quarter ended June 30.
The company reported an adjusted profit of $6.72 per share, compared with analysts' average estimate of $6.41.
Reporting by Sriparna Roy in Bengaluru and Amina Niasse in New York City; Editing by Shinjini Ganguli
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
